Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Vermersch

Showing results (131-140 of 250) with videos related to

Pageof 25
Sort By:
Arthritis and Rheumatism|October 2, 2007
Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approachDidier Lefranc, David Launay, Sylvain Dubucquoi, et al.
Neurology|May 22, 2020
Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MSJean-Baptiste Davion, Renaud Lopes, Élodie Drumez, et al.
Plos One|July 2, 2015
An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of AutoantibodiesVirginie Dutoit-Lefèvre, Sylvain Dubucquoi, David Launay, et al.
The New England Journal of Medicine|January 22, 2010
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosisGavin Giovannoni, Giancarlo Comi, Stuart Cook, et al.
Ophthalmology|November 2, 2010
Kjellin syndrome: long-term neuro-ophthalmologic follow-up and novel mutations in the SPG11 geneBernard Puech, Arnaud Lacour, Giovanni Stevanin, et al.
Journal of Neurology|December 25, 2012
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY studyGiancarlo Comi, Stuart D Cook, Gavin Giovannoni, et al.
Frontiers in Immunology|June 29, 2026
Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosisCelia Oreja-Guevara, Sven G Meuth, Nikos Grigoriadis, et al.
Therapeutic Advances in Neurological Disorders|December 13, 2021
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practicePeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Muscle & Nerve|November 19, 2016
Bent spine syndrome as the initial symptom of late-onset Pompe diseaseNicolas Taisne, Claude Desnuelle, Raul Juntas Morales, et al.
Annals of Neurology|August 30, 2018
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trialJerry S Wolinsky, Xavier Montalban, Stephen L Hauser, et al.
Pageof 25

Showing results (131-140 of 250) with videos related to

Sort By:
Pageof 25
Arthritis and Rheumatism|October 2, 2007
Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approachDidier Lefranc, David Launay, Sylvain Dubucquoi, et al.
Neurology|May 22, 2020
Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MSJean-Baptiste Davion, Renaud Lopes, Élodie Drumez, et al.
Plos One|July 2, 2015
An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of AutoantibodiesVirginie Dutoit-Lefèvre, Sylvain Dubucquoi, David Launay, et al.
The New England Journal of Medicine|January 22, 2010
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosisGavin Giovannoni, Giancarlo Comi, Stuart Cook, et al.
Ophthalmology|November 2, 2010
Kjellin syndrome: long-term neuro-ophthalmologic follow-up and novel mutations in the SPG11 geneBernard Puech, Arnaud Lacour, Giovanni Stevanin, et al.
Journal of Neurology|December 25, 2012
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY studyGiancarlo Comi, Stuart D Cook, Gavin Giovannoni, et al.
Frontiers in Immunology|June 29, 2026
Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosisCelia Oreja-Guevara, Sven G Meuth, Nikos Grigoriadis, et al.
Therapeutic Advances in Neurological Disorders|December 13, 2021
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practicePeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Muscle & Nerve|November 19, 2016
Bent spine syndrome as the initial symptom of late-onset Pompe diseaseNicolas Taisne, Claude Desnuelle, Raul Juntas Morales, et al.
Annals of Neurology|August 30, 2018
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trialJerry S Wolinsky, Xavier Montalban, Stephen L Hauser, et al.
Pageof 25